Activation of intestinal peroxisome proliferator-activated receptor- increases high-density lipoprotein production
Author(s) -
S. Colin,
Olivier Briand,
Véronique Touche,
Kristiaan Wouters,
Morgane Baron,
François Pattou,
Rémy Hanf,
Anne Tailleux,
Giulia Chinetti,
Bart Staels,
Sophie Lestavel
Publication year - 2012
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1093/eurheartj/ehs227
Subject(s) - chylomicron , medicine , endocrinology , fenofibrate , peroxisome proliferator activated receptor , apolipoprotein b , receptor , peroxisome , liver x receptor , lipoprotein , lipid metabolism , peroxisome proliferator activated receptor alpha , ldl receptor , fibrate , cholesterol , nuclear receptor , biology , biochemistry , transcription factor , very low density lipoprotein , gene
Peroxisome proliferator-activated receptor (PPAR)-α is a transcription factor controlling lipid metabolism in liver, heart, muscle, and macrophages. Peroxisome proliferator-activated receptor-α activation increases plasma HDL cholesterol and exerts hypotriglyceridaemic actions via the liver. However, the intestine expresses PPAR-α, produces HDL and chylomicrons, and is exposed to diet-derived PPAR-α ligands. Therefore, we examined the effects of PPAR-α activation on intestinal lipid and lipoprotein metabolism.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom